Literature DB >> 15820334

The soluble leptin receptor in olanzapine-induced weight gain: results from a prospective study.

Christoph Ebenbichler, Markus Laimer, Michael Kranebitter, Monika Lechleitner, Josef R Patsch, Susanne Baumgartner, Monika Edlinger, Alex Hofer, Martina Hummer, Maria A Rettenbacher, W Wolfgang Fleischhacker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820334     DOI: 10.1016/j.schres.2004.10.012

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  6 in total

1.  To: Mackin P, Watkinson HM, Young AH (2005) Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study. Diabetologia 48:215-221.

Authors:  J Engl; M Laimer; W W Fleischhacker; C F Ebenbichler
Journal:  Diabetologia       Date:  2005-06-03       Impact factor: 10.122

Review 2.  Atypical antipsychotic-induced weight gain: insights into mechanisms of action.

Authors:  James L Roerig; Kristine J Steffen; James E Mitchell
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

3.  Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis.

Authors:  Stéphane Potvin; Simon Zhornitsky; Emmanuel Stip
Journal:  Can J Psychiatry       Date:  2015-03       Impact factor: 4.356

Review 4.  Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin.

Authors:  Hua Jin; Jonathan M Meyer; Sunder Mudaliar; Dilip V Jeste
Journal:  Schizophr Res       Date:  2008-01-18       Impact factor: 4.939

Review 5.  Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review.

Authors:  Othman Sentissi; Jacques Epelbaum; Jean-Pierre Olié; Marie-France Poirier
Journal:  Schizophr Bull       Date:  2007-12-28       Impact factor: 9.306

6.  Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia.

Authors:  Nobuto Tsuneyama; Yutaro Suzuki; Kazushi Sawamura; Takuro Sugai; Naoki Fukui; Junzo Watanabe; Shin Ono; Mami Saito; Toshiyuki Someya
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.